Wave Life Sciences (WVE) Director Tan Aik Na Sells 432 Shares

What Happened Tan Aik Na, a director of Wave Life Sciences (WVE), sold 432 shares of common stock on August 11, 2026 at $6.01 per share, generating proceeds of approximately $2,596. The filing indicates the sale was made pursuant to a previously adopted 10b5-1 trading plan and was executed to cover tax withholding associated with restricted stock unit (RSU) vesting that same day.

Key Details

• Transaction date: August 11, 2026; Form 4 filed August 13, 2026 (timely).
• Sale: 432 shares at $6.01 each; total proceeds ≈ $2,596.
• Reason/footnote: Shares sold solely to cover taxes on RSU vesting; executed under an existing 10b5-1 plan.
• Shares owned after transaction: Not disclosed in the filing.
• Filing includes Exhibit 24.1 (Power of Attorney).
• No indication this was a large/10% owner transaction; it appears routine and tax-related.

Context Sales made under a 10b5-1 plan and those solely to cover tax withholding after RSU vesting are typically considered routine and not a direct signal of insider view on the stock. The filing also notes Wave’s redomiciliation (Aug 7, 2026) from Wave Life Sciences Ltd. (Singapore) to Wave Life Sciences, Inc. (Delaware), which changed domicile but did not alter securityholder proportions.